Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.420
-0.010 (-0.41%)
At close: Oct 7, 2025, 4:00 PM EDT
2.450
+0.030 (1.24%)
After-hours: Oct 7, 2025, 4:57 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $7.18 million as of October 7, 2025. Its market cap has increased by 98.40% in one year.
Market Cap
7.18M
Enterprise Value
5.43M
1-Year Change
98.40%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $7.18M, a decrease of -99.99%. That is a compound annual growth rate of -69.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 7.21M | -32.09% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | 18.67B | 21.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 763.67B |
| Johnson & Johnson | 455.42B |
| AbbVie | 406.13B |
| UnitedHealth Group | 326.50B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.86B |